Kb Financial Partners, LLC Moderna, Inc. Transaction History

Kb Financial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $1,659 - $2,247	14 New	14 $2,000
Q4 2022 Feb 17, 2023	SELL	$118.38 - $210.04 $1,538 - $2,730	-13 Reduced 30.95%	29 $5,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $3,542 - $5,825	30 Added 250.0%	42 $5,000
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $1,405 - $2,119	12 New	12 $2,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kb Financial Partners, LLC with notifications on news.